Published: 2015-04-05

Diabetes in India: a long way to go

Monica Gupta, Ram Singh, S. S. Lehl


Diabetes mellitus, a major lifestyle disease is undoubtedly the most challenging public health problem of 21st century with a worldwide prevalence of 387 million (8.3%) and predicted to be 592 million by 2035. 77% of people with diabetes live in low- and middle-income countries. India, once known as the ‘diabetes capital of the world’ was home to 61.3 million patients with T2DM in 2011 with predictions of 101.2 million diabetics by 2030. India is second only to China which is home to 92.3 million diabetics. The International Diabetes Federation estimated a doubling of diabetic population between 1995 and 2005, and predicted 70 million diabetics by 2025.

Full Text:



International Diabetes Federation. IDF diabetes atlas. In: IDF, eds. A Book. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J. 2014;7:45-8.

Mohan V, Madan Z, Jha R, Deepa R, Pradeepa R. Diabetes social and economic perspectives in the new Millennium. Int J Diab Dev Countries. 2004;24:29-35.

International Diabetes Federation. IDF diabetes atlas. In: IDF, eds. A Book. 6th ed. 4th ed. Brussels, Belgium: International Diabetes Federation; 2009.

Ramachandran A, Snehalatha C, Kapur A, Vijay V, MohanV, Das AK, et al. Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094-101.

Global Forum Health. Risk factor surveillance for non-communicable diseases (NCDs): the multi-site ICMR-WHO collaborative initiative, 2015. Available at:

World Health Organization. 10 facts about diabetes, 2013. Available at:

Radha V, Mohan V. Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res. 2007;125(3):259-74.

Joshi SR, Das AK, Vijay VJ, Mohan V. Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control. J Assoc Physicians India. 2008;56:443-50.

Moses CR, Seshiah V, Sahay BK, Kumar A, Asirvatham AJ, Balaji V, et al. Baseline results indicate poor glycemic control and delay in initiation and optimization of insulin therapy: results from the improving management practices and clinical outcomes in type 2 diabetes study. Indian J Endocrinol Metab. 2012;16(Suppl 2):S432-3.

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-79.

Unnikrishnan RI, Anjana RM, Mohan V. Importance of controlling diabetes early–The concept of metabolic memory, legacy effect and the case for early insulinisation. J Assoc Physicians India. 2011;59(Suppl):8-12.

Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chattergee A, et al. High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J Obes. 2004;28:1217-26.

Mohan V, Deepa M, Deepa R, Shantirani CS, Farooq S, Ganesan A, et al. Secular trends in the prevalence of diabetes and glucose tolerance in urban South India - the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia. 2006;49:1175-8.

Suresh S, Deepa R, Pradeepa R, Rema M, Mohan V. Large-scale diabetes awareness and prevention in South India. Diabetes Voice. 2005;50:11-4.